Alnylam Pharmaceuticals
Develops novel therapeutics-based RNAi and provides overviews of recent drug development programs. Learn more
Launch date
Employees
Market cap
€30.5b
Enterprise valuation
€29.3b (Public information from Sep 2024)
Share price
$276.32999 ALNY
Cambridge Massachusetts (HQ)
Authorizing premium user...